Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | opioid receptor, kappa 1 | Starlite/ChEMBL | References |
Homo sapiens | opioid receptor, mu 1 | Starlite/ChEMBL | References |
Homo sapiens | opioid receptor, delta 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tm gpcr rhodopsin | Get druggable targets OG5_139759 | All targets in OG5_139759 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | Get druggable targets OG5_139759 | All targets in OG5_139759 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Possible alanine rich oxidoreductase | 0.069 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.069 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | trans-2-enoyl-ACP reductase, FabK | 0.069 | 1 | 0.5 |
Trichomonas vaginalis | 2-nitropropane dioxygenase precursor, putative | 0.069 | 1 | 0.5 |
Mycobacterium ulcerans | 2-nitropropane dioxygenase | 0.069 | 1 | 0.5 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0634 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.069 | 1 | 0.5 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0634 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 5.2 nM | Agonist activity at human cloned delta opioid receptor assessed as stimulation of [35S]GTPgammaS binding | ChEMBL. | 17350835 |
EC50 (functional) | = 5.2 nM | Agonist activity at human cloned delta opioid receptor assessed as stimulation of [35S]GTPgammaS binding | ChEMBL. | 17350835 |
EC50 (functional) | = 140 nM | Agonist activity at human cloned mu opioid receptor assessed as stimulation of [35S]GTPgammaS binding | ChEMBL. | 17350835 |
EC50 (functional) | = 140 nM | Agonist activity at human cloned mu opioid receptor assessed as stimulation of [35S]GTPgammaS binding | ChEMBL. | 17350835 |
Ki (binding) | = 1.8 nM | Displacement of [3H]diprenorphine from human cloned delta opioid receptor | ChEMBL. | 17350835 |
Ki (binding) | = 1.8 nM | Displacement of [3H]diprenorphine from human cloned delta opioid receptor | ChEMBL. | 17350835 |
Ki (binding) | = 28 nM | Displacement of [3H]diprenorphine from human cloned mu opioid receptor | ChEMBL. | 17350835 |
Ki (binding) | = 28 nM | Displacement of [3H]diprenorphine from human cloned mu opioid receptor | ChEMBL. | 17350835 |
Ki (binding) | = 1030 nM | Displacement of [3H]diprenorphine from human cloned kappa opioid receptor | ChEMBL. | 17350835 |
Ki (binding) | = 1030 nM | Displacement of [3H]diprenorphine from human cloned kappa opioid receptor | ChEMBL. | 17350835 |
Ratio Ki (binding) | = 1.6 | Selectivity for human cloned delta opioid receptor over human cloned mu opioid receptor | ChEMBL. | 17350835 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.